Literature DB >> 6776977

Potential therapeutic applications of aspirin and other cyclo-oxygenase inhibitors.

A E Farah, F Rosenberg.   

Abstract

1 The ubiquitous actions of the cyclo-oxygenase inhibitors are described. 2 These include the inhibitory effect on prostaglandin synthesis and the direct effect of aspirin on lymphocytes and their ability to produce lymphokines. 3 Aspirin reduces some types of platelet aggregation possibly involving inhibition of the precursors of thromboxane A2 and prostacyclin. 4 The therapeutic implications in relation to transient ischaemic attacks, coronary artery disease and reno-allograft rejection are discussed. 5 The beneficial and adverse effects on the gastro-intestinal tract are described. 6 The effects of aspirin-like drugs on the genito-urinary tract are described with particular reference to their adverse effects on labour and their therapeutic effect on dysmenorrhoea.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6776977      PMCID: PMC1430184          DOI: 10.1111/j.1365-2125.1980.tb01809.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  167 in total

Review 1.  Prostaglandins as factors in diseases of the alimentary tract.

Authors:  A Bennett
Journal:  Adv Prostaglandin Thromboxane Res       Date:  1976

2.  Encrustation and atherosclerosis: the analogy between early in vivo lesions and deposits which occur in extracorporeal circulations.

Authors:  E A MURPHY; H C ROWSELL; H G DOWNIE; G A ROBINSON; J F MUSTARD
Journal:  Can Med Assoc J       Date:  1962-08-11       Impact factor: 8.262

3.  Relationship of bone destruction in skeletal metastases to osteoclast activation and prostaglandins.

Authors:  C S Galasko; A Bennett
Journal:  Nature       Date:  1976-10-07       Impact factor: 49.962

4.  Control of lymphokine secretion by prostaglandins.

Authors:  D Gordon; M A Bray; J Morley
Journal:  Nature       Date:  1976-07-29       Impact factor: 49.962

5.  The effect of prostaglandin F 2alpha on the progestogen content of ovaries from pseudopregnant rats.

Authors:  B B Pharriss; L J Wyngarden
Journal:  Proc Soc Exp Biol Med       Date:  1969-01

6.  Antiinflammatory agents and inhibition of ocular prostaglandin synthetase.

Authors:  E C Ku; C Signor; E Eakins
Journal:  Adv Prostaglandin Thromboxane Res       Date:  1976

7.  Inhibition of prostaglandin synthetase by aspirin-like drugs in different microsomal preparations.

Authors:  A Dembinska-Kieĉ; A Zmuda; J Krupinska
Journal:  Adv Prostaglandin Thromboxane Res       Date:  1976

8.  The effect of indomethacin on spontaneous activity in the isolated human myometrium and on the response to oxytocin and prostaglandin.

Authors:  D B Garrioch
Journal:  Br J Obstet Gynaecol       Date:  1978-01

9.  Sex differences in the antithrombotic effects of aspirin.

Authors:  J G Kelton; J Hirsh; C J Carter; M R Buchanan
Journal:  Blood       Date:  1978-11       Impact factor: 22.113

10.  The effect of salicylates on the hemostatic properties of platelets in man.

Authors:  H J Weiss; L M Aledort; S Kochwa
Journal:  J Clin Invest       Date:  1968-09       Impact factor: 14.808

View more
  6 in total

1.  Salate derivatives found in sunscreens block experimental autoimmune encephalomyelitis in mice.

Authors:  Yanping Wang; Steven J Marling; Lori A Plum; Hector F DeLuca
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-24       Impact factor: 11.205

2.  c-Myc modulation: a key role in melanoma drug response.

Authors:  Annalisa Fico; Daniela Alfano; Anna Valentino; Valeria Vasta; Ernesta Cavalcanti; Salvatore Travali; Eduardo J Patriarca; Emilia Caputo
Journal:  Cancer Biol Ther       Date:  2015-04-02       Impact factor: 4.742

Review 3.  Aspirin and related derivatives of salicylic acid.

Authors:  S P Clissold
Journal:  Drugs       Date:  1986       Impact factor: 9.546

4.  Plasma levels of aspirin following effervescent and enteric coated tablets, and their effect on platelet function.

Authors:  L M Ross-Lee; M J Elms; B E Cham; F Bochner; I H Bunce; M J Eadie
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

Review 5.  Topical bromfenac for prevention and treatment of cystoid macular edema following cataract surgery: a review.

Authors:  John D Sheppard
Journal:  Clin Ophthalmol       Date:  2016-10-25

6.  Effect of 0.1% Bromfenac for Preventing Macular Edema after Cataract Surgery in Patients with Diabetes.

Authors:  Seok Hyeon Song; Seung Kook Baek; Min Woo Lee; Young Hoon Lee
Journal:  Korean J Ophthalmol       Date:  2020-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.